GlycoSeLect ^Hubs

GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), enhanced tools for the analysis and selective purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in: Basic R&D, Glycobiology & Glycoproteomics, Biomarker Discover & Biomedical Diagnostics, The Biopharmaceutical Industry, Vaccines, Cosmetics GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant advantages over existing commercially available lectins products including: Simplified, rapid & cost effective production through recombinant expression in Escherichia coli, High purity & consistent performance, Genetically enhanced glycan binding properties (specificity & affinity), Scalable production facilitating utilization for large scale applications.